Sagimet Biosciences, Inc. (SGMT)
9.42
+0.30
(+3.29%)
USD |
NASDAQ |
Nov 06, 10:27
Sagimet Biosciences EPS Diluted (Quarterly) : -0.2627 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2627 |
| March 31, 2026 | -0.3271 |
| December 31, 2025 | -0.2942 |
| September 30, 2025 | -0.3976 |
| June 30, 2025 | -0.3226 |
| March 31, 2025 | -0.5646 |
| December 31, 2024 | -0.5032 |
| September 30, 2024 | -0.4548 |
| June 30, 2024 | -0.2544 |
| Date | Value |
|---|---|
| March 31, 2024 | -0.2283 |
| December 31, 2023 | -0.356 |
| September 30, 2023 | -0.2972 |
| June 30, 2023 | -0.3174 |
| March 31, 2023 | -0.3082 |
| June 30, 2022 | -0.3322 |
| March 31, 2022 | -0.4086 |
| March 31, 2021 | -0.2596 |
| March 31, 2020 | -0.1863 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | -0.3731 |
| IDEAYA Biosciences, Inc. | -1.222 |
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Anika Therapeutics, Inc. | 0.2412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.95M |
| Total Expenses (Quarterly) | 13.95M |
| Enterprise Value | 325.27M |
| Earnings Yield | -13.61% |
| Normalized Earnings Yield | -13.61 |